President's Letter


Dear Fellow Shareholders,

Both domestic and international stock markets produced moderate gains in the first quarter, extending the worldwide recovery in stock prices that began roughly a year ago. All of our funds had positive returns and achieved new highs in net asset value during the quarter. We are pleased that our disciplined value investment style continues to reward our shareholders.

The Economy and the Market

The U.S. economy continues to grow at a healthy rate. Low interest rates and low inflation are fueling this growth. In addition, employment growth accelerated significantly in the past quarter, and corporate earnings also showed significant improvement, aided by high productivity growth. Many of these same factors are also driving strong economic growth internationally.

Despite the mostly positive economic headlines, our outlook for stock returns remains tempered by valuation. Most broad market indices are up 35% or more in the past 12 months. We believe U.S. market valuations now broadly reflect assumptions of sustained, robust economic recovery. While our analysis indicates that our holdings are priced at discounts to growing business values, finding new stock ideas that sell at deep discounts has become more difficult. We are finding more stock values internationally, but discounts to value have narrowed there, too.

We still believe that stocks' prospective returns are attractive compared to other asset classes. However, we also believe that higher share valuations make this a stock pickers' market. Values exist, but they are tougher to find. The rigors of our disciplined, bottom-up investment process, which focuses on finding undervalued stocks, help us to take advantage of market volatility and to unearth value in today's market. Our patient, long-term approach, which helps us avoid over reacting to short term events, gives us an extra edge.

Industry Governance and Regulation

Over the past quarter, the SEC and Congress have proposed several new rules and regulations for the mutual fund industry in response to abusive practices by fund companies. We believe in setting high standards for the treatment of our shareholders, but we also believe that abuses by other fund companies harm investors and their confidence in our industry. In this spirit, we support and encourage sensible new rules and regulations to protect fund investors and enhance fund governance. If you would like to learn more about our position on these issues, please visit our web site at www.oakmark.com.

Thank you for your continued investment and confidence in the Oakmark Family of Funds. We welcome your comments and questions. You can reach us via e-mail at ContactOakmark@oakmark.com.

John R. Raitt signature

John R. Raitt
President of The Oakmark Funds
President and CEO of Harris Associates L.P.

  

THE OAKMARK FAMILY OF FUNDS

Summary Information


Performance for Period1
Ended
March 31, 2004
The Oakmark
Fund-Class I

(OAKMX)
The Oakmark
Select
Fund
-Class I
(OAKLX)

The Oakmark
Small Cap
Fund
-Class I
(OAKSX)

The Oakmark
Equity and
Income Fund
-Class I
(OAKBX)
3 Months* 1.44%

2.45%

7.03%

4.18%
6 Months* 12.95% 14.26% 18.74% 13.75%
1 Year 32.53% 32.83% 46.87% 31.35%
Average Annual Total
Return for:

3 Year

 

6.22%

 

9.59%

 

12.30%

 

12.48%

5 Year 5.29%

13.66%

9.44% 13.89%
10 Year 11.54% N/A N/A N/A
Since inception 16.91%
(8/5/91)
21.81%
(11/1/96)
11.62%
(11/1/95)
14.90%
(11/1/95)
Value of $10,000
from inception date
$72,327 $43,214 $25,239 $32,200
Top Five Equity Holdings
as of
March 31, 20042

 

 

Company and % of Total
Net Assets

Washington
Mutual, Inc.
3.4% Washington
Mutual, Inc.
17.0% Checkpoint Systems, Inc. 4.6% Burlington Resources, Inc. 3.4%
First Data  Corporation 2.6% H&R Block, Inc. 7.3% Ciber, Inc. 4.5% Caremark Rx, Inc. 3.4%
H&R Block, Inc. 2.5% Yum! Brands, Inc. 6.0% Hanger Orthopedic Group, Inc. 4.3% First Data  Corporation 3.2%
McDonald's Corporation 2.4% First Data  Corporation 5.7% Mentor Graphics Corporation 4.3% Cardinal Health, Inc. 2.8%
Yum! Brands, Inc. 2.4% Burlington Resources, Inc. 4.7% Ralcorp Holdings, Inc. 3.9% General Dynamics Corporation 2.6%
Top Five Industries
as of
March 31, 2004

 

Industries and % of Total Net Assets

Retail 9.6% Banks & Thrifts 17.0% Food & Beverage 10.3% U.S. Government
Notes
25.0%
Food & Beverage 8.3% Retail 14.0% Computer Software 9.9% Oil & Natural Gas 6.6%
Pharmaceuticals 7.8% Other Consumer Goods & Services 11.2% Medical Products 8.3% Health Care Services 6.6%
Banks & Thrifts 6.4% Information & Services 7.4% Computer Services 4.9% Retail 6.0%
Cable Systems & Satellite TV 6.2% Pharmaceuticals 6.4% Banks & Thrifts 4.8% Aerospace & Defense 5.4%

  

Performance for Period1
Ended
March 31, 2004
The Oakmark
Global
Fund-Class I
(OAKGX)
The Oakmark
International
Fund-Class I
(OAKIX)
The Oakmark
International
Small Cap Fund-Class I
(OAKEX)
3 Months*

3.89%

3.61%

6.54%

6 Months*

18.31%

19.93%

25.51%

1 Year 73.04%

62.00%

85.03%

Average Annual Total
Return for:

3 Year

 

22.33%

 

10.80%

 

19.01%

5 Year N/A 11.36% 14.37%
10 Year N/A 9.08% N/A
Since inception 17.29%3
(8/4/99)
11.89%
(9/30/92)
11.85%
(11/1/95)
Value of $10,000 from
inception date
$21,029 $36,419 $25,685
Top Five Equity Holdings
as of
March 31, 20042

 

Company and % of Total
Net Assets

Diageo plc

4.7%

Diageo plc

3.5%

Neopost SA

4.3%
First Data Corporation 4.7%

Aventis S.A.

3.5%

D.F.S. Furniture Company plc 3.8%
Nestle SA 4.1% Euronext NV 3.4% Schlinder Holding AG 3.7%
Euronext NV 4.0% GlaxoSmithKline plc 3.3% Kobenhavns Lufthavne
A/S (Copenhagen Airports A/S CPH)
3.6%
Takeda Chemical Industries, Ltd. 3.8% Takeda Chemical Industries, Ltd. 3.0% Ansell Limited 3.6%
Top Five Industries
as of
March 31, 2004

 

Industries and % of Total
Net Assets

Food & Beverage 11.9% Food & Beverage 14.4% Retail 9.4%
Pharmaceuticals 10.5% Pharmaceuticals 12.1% Airport Maintenance 7.0%
Banks & Thrifts 7.3% Banks & Thrifts 11.7% Machinery & Industrial Processing 6.2%
Other Financial 6.6% Chemicals 8.1% Diversified Conglomerates 6.1%
Computer Services 6.3% Other Financial 7.4% Medical Products 6.0%

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. Average annual total return measures annualized change, while total return measures aggregate change. To obtain current month end performance data call 1-800-OAKMARK.

* Not annualized